Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16673135 | 0.89 | ALDH1A1 (0.58) | ALDH1A1TSHRL3MBTL1LMNAKMT2A | |
| SCHEMBL14408397 | 0.89 | ALDH1A1 (0.58) | ALDH1A1TSHRL3MBTL1LMNAKMT2A | |
| SCHEMBL27583131 | 0.86 | L3MBTL1 (0.64) | ALDH1A1TSHRL3MBTL1LMNAKMT2A | |
| SCHEMBL10472516 | 0.86 | L3MBTL1 (0.64) | ALDH1A1TSHRL3MBTL1LMNAKMT2A | |
| SCHEMBL3813646 | 0.86 | L3MBTL1 (0.64) | ALDH1A1TSHRL3MBTL1LMNAKMT2A | |
| SCHEMBL2384186 | 0.84 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1LMNAKMT2ASLC1A3 | |
| SCHEMBL584760 | 0.84 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1LMNAKMT2ASLC1A3 | |
| SCHEMBL584761 | 0.84 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1LMNAKMT2ASLC1A3 | |
| SCHEMBL16672927 | 0.83 | LMNA (0.50) | ALDH1A1TSHRL3MBTL1LMNAKMT2A | |
| SCHEMBL28008702 | 0.83 | TSHR (0.54) | ALDH1A1TSHRL3MBTL1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230381332-A1 | Deuterated Camptothecin Derivative And Antibody-drug Conjugate Thereof | BAILI BIO CHENGDU PHARMACEUTICAL CO LTD (CN) | 2023-11-30 | — | — | US | disclosed |
| EP-4227309-A1 | DEUTERATED CAMPTOTHECIN DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF | Sichuan Baili Pharmaceutical Co. Ltd. (CN) | 2023-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230381332-A1 | Deuterated Camptothecin Derivative And Antibody-drug Conjugate Thereof | DCTD, CD38, CDA | ALDH1A1 910/4885TSHR 1531/4885L3MBTL1 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.